Literature DB >> 31241423

Hepatoprotective Effect of Probiotic Lactobacillus rhamnosus GG Through the Modulation of Gut Permeability and Inflammasomes in a Model of Alcoholic Liver Disease in Zebrafish.

Juliana Paula Bruch-Bertani1,2, Carolina Uribe-Cruz1,2, Amanda Pasqualotto1,2, Larisse Longo1,2, Raquel Ayres1, Carolina Bortolin Beskow1,2, Afonso Luis Barth3, Daiana Lima-Morales3, Fábio Meurer4, Gabriel Tayguara Silveira Guerreiro1, Themis Reverbel da Silveira1,2, Mário Reis Álvares-da-Silva1,2,5, Valesca Dall'Alba1,2,6.   

Abstract

Objective: Alcoholic liver disease (ALD) is among the leading causes of death from liver disease. Among the factors involved in its pathogenesis are inflammation and increased intestinal permeability. The aim of this study was to assess the effect of Lactobacillus rhamnosus GG (LGG) on hepatic lipid accumulation, activation of inflammasomes, and gut permeability markers in experimental model of ALD with zebrafish.
Methods: An experiment was conducted to assess the effective LGG dose capable of promoting intestinal colonization. Animals were divided into three groups (n = 64/group): ethanol group (E), ethanol + probiotic group (EP), and control group (C). Groups E and EP were exposed to 0.5% ethanol concentration for 28 days. At the end of this period, animals were euthanized, and livers were collected for Oil Red staining and assessment of the inflammasome system. Intestines were collected for evaluation of gut permeability markers.
Results: The dose of 1.55 × 106 UFC LGG/fish/d promoted intestinal colonization. Group EP presented lower hepatic lipid accumulation, lower il-1β expression, and higher cldn15a expression when compared to group E.Conclusions: Supplementation with LGG was protective for hepatic steatosis in ALD model. In addition, LGG influenced the modulation of the inflammatory response and markers of gut permeability, improving the gut barrier structure.

Entities:  

Keywords:  Lactobacillus rhamnosus GG; alcoholic liver disease; inflammasomes; probiotics; zebrafish

Mesh:

Substances:

Year:  2019        PMID: 31241423     DOI: 10.1080/07315724.2019.1627955

Source DB:  PubMed          Journal:  J Am Coll Nutr        ISSN: 0731-5724            Impact factor:   3.169


  7 in total

1.  Protective effects of vitamin D against injury in intestinal epithelium.

Authors:  Carol Lee; Ethan Lau; Sinobol Chusilp; Rachel Filler; Bo Li; Haitao Zhu; Masaya Yamoto; Agostino Pierro
Journal:  Pediatr Surg Int       Date:  2019-10-14       Impact factor: 1.827

2.  The amelioration of alcohol-induced liver and intestinal barrier injury by Lactobacillus rhamnosus Gorbach-Goldin (LGG) is dependent on Interleukin 22 (IL-22) expression.

Authors:  Yuli Ge; Huiling Sun; Lanman Xu; Weiping Zhang; Jiaojian Lv; Yongping Chen
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

3.  Effects of probiotics on Zebrafish model infected with Aeromonas hydrophila: spatial distribution, antimicrobial, and histopathological investigation.

Authors:  Sheida Ehsannia; Hamed Ahari; Shapour Kakoolaki; Seyed Amirali Anvar; Shima Yousefi
Journal:  BMC Microbiol       Date:  2022-06-27       Impact factor: 4.465

Review 4.  Zebrafish in Inflammasome Research.

Authors:  Gabriel Forn-Cuní; Annemarie H Meijer; Monica Varela
Journal:  Cells       Date:  2019-08-15       Impact factor: 6.600

5.  Jian-Gan-Xiao-Zhi Decoction Alleviates Inflammatory Response in Nonalcoholic Fatty Liver Disease Model Rats through Modulating Gut Microbiota.

Authors:  Jiabao Liao; Xuehua Xie; Jinmei Gao; Zhaiyi Zhang; Fei Qu; Huantian Cui; Yongjun Cao; Xue Han; Jie Zhao; Weibo Wen; Hongwu Wang
Journal:  Evid Based Complement Alternat Med       Date:  2021-03-20       Impact factor: 2.629

Review 6.  Probiotics: Evolving as a Potential Therapeutic Option against Acetaminophen-Induced Hepatotoxicity.

Authors:  Saikat Dewanjee; Tarun K Dua; Paramita Paul; Abhijit Dey; Jayalakshmi Vallamkondu; Sonalinandini Samanta; Ramesh Kandimalla; Vincenzo De Feo
Journal:  Biomedicines       Date:  2022-06-24

Review 7.  Liver-specific drug delivery platforms: Applications for the treatment of alcohol-associated liver disease.

Authors:  Jeffrey Barr Warner; Steven Corrigan Guenthner; Josiah Everett Hardesty; Craig James McClain; Dennis Ray Warner; Irina Andreyevna Kirpich
Journal:  World J Gastroenterol       Date:  2022-09-28       Impact factor: 5.374

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.